| Criteria | Documentation Score, % (n/N) |
|---|---|
| Items evaluated once during the entire audit period | |
| Cardiovascular risk factors | 96.7 (145/150) |
| Identified BP goal | 18.7 (28/150) |
| BP goal communicated to patient | 10.7 (16/150) |
| Patient is treated with monotherapy when appropriate (stage 1 HTN) | 100.0 (67/67) |
| Patient is treated with combination therapy when appropriate (stage 2 HTN or stage 1 HTN with comorbidities) | 97.7 (83/85) |
| Fasting lipid profile* | 92.6 (138/149) |
| Patients with diabetes or CKD screened for urine albumin* | 68.8 (53/77) |
| Serum creatinine* | 96.7 (145/150) |
| Blood glucose* | 96.7 (145/150) |
| Hematocrit* | 69.8 (104/149) |
| Serum potassium* | 96.7 (145/150) |
| Serum calcium* | 96.7 (145/150) |
| EKG performed at any point | 78.0 (117/150) |
| Items evaluated during multiple visits | |
| Absence of BP control mentioned in progress note when applicable | 88.7 (63/71) |
| Discussion of lifestyle modification documented for at least 50% of visits in audit period | 22.0 (33/150) |
↵* Measured within the past 12 months.
BP, blood pressure; CKD, chronic kidney disease; EKG, electrocardiogram; HTN, hypertension.